Yadiel Rivera-Nieves
Endocrinology, Diabetes & Metabolism · Mayaguez, PRNPI 1205368347
Payments from drug & device makers
Across 140 payments — averaging $24.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$723
- Novo Nordisk$480
- Sanofi-aventis U.S. LLC$397
- Amgen$310
- PBG Puerto Rico LLC$294
- AstraZeneca$267
- plus $969 from 10 others
What the payments were for
- Food & beverage$3,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 21 | $723 |
| Novo Nordisk | 24 | $480 |
| Sanofi-aventis U.S. LLC | 19 | $397 |
| Amgen(2 entities) | 5 | $310 |
| PBG Puerto Rico LLC | 14 | $294 |
| AstraZeneca | 17 | $267 |
| Bayer | 2 | $202 |
| Abbott | 7 | $141 |
| Merck | 8 | $137 |
| Dexcom, Inc. | 7 | $135 |
| Johnson & Johnson | 5 | $113 |
| Eli Lilly Export S.A. Puerto Rico Branch | 4 | $90 |
| AbbVie | 3 | $61 |
| Novartis | 2 | $46 |
| Medtronic | 1 | $23 |
| Insulet Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,439 in reported general payments places this provider in the 35th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 517 | $512,791 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 328 | $205,672 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 300 | $191,545 |
| FarxigaDapagliflozin Propanediol | 211 | $130,030 |
| OzempicSemaglutide | 126 | $123,078 |
| TradjentaLinagliptin | 190 | $106,673 |
| JardianceEmpagliflozin | 142 | $101,524 |
| JentaduetoLinagliptin/Metformin Hcl | 133 | $70,251 |
| Jentadueto XrLinagliptin/Metformin Hcl | 124 | $69,136 |
| GlyxambiEmpagliflozin/Linagliptin | 109 | $67,513 |
| Xigduo XrDapaglifloz Propaned/Metformin | 111 | $66,435 |
| SynjardyEmpagliflozin/Metformin Hcl | 83 | $54,889 |
| SynthroidLevothyroxine Sodium | 988 | $45,930 |
| LantusInsulin Glargine,hum.Rec.Anlog | 479 | $43,701 |
| Repatha SureclickEvolocumab | 36 | $20,400 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy Xr, Trijardy Xr, Tradjenta, Jardiance, Jentadueto | $723 | $867,2031,409 claims |
| AstraZenecaFarxiga | $267 | $130,030211 claims |
| Novo NordiskOzempic | $480 | $123,078126 claims |
| Sanofi-aventis U.S. LLCLantus, Soliqua 100-33 | $397 | $58,781496 claims |
| AbbVieSynthroid | $61 | $45,930988 claims |
| BayerKerendia | $202 | $11,86312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in Mayaguez
- Carlos Martinez RiveraMayaguez$9K
- Rose Roman TorresMayaguez$7K
- Angel Comulada RiveraBayamon$8.9M
- Ramon Ortiz CarrasquilloManati$6M
- Alex Gonzalez BossoloSan Juan$5.5M
- Martha GomezSan Juan$3.8M
- Paola Mansilla-LetelierBayamon$3.1M
- Altagracia Alcantara GonzalezBayamon$1M
- Myriam Allende-VigoHumacao$963K
- Jose Garcia MateoPonce$945K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.